Bacterial Infection: Antimicrobial Therapies Archives - Institute for Bioengineering of Catalonia

May 8, 2025

Common lung bacteria team up to evade immune defences

A study led by the Institute for Bioengineering of Catalonia (IBEC) and the Universitat Autònoma de Barcelona (UAB) has uncovered how co-infection by Pseudomonas aeruginosa and Mycobacterium abscessus, two common lung pathogens, can suppress immune responses and worsen outcomes in patients with respiratory diseases. The findings, published today in the journal Virulence, provide new insight into why polymicrobial infections are particularly difficult to treat and open the door to new therapeutic strategies.

January 15, 2025

Eduard Torrents receives the ICREA Academia programme distinction

IBEC researcher Eduard Torrents has been awarded the ICREA Academia distinction by the Catalan Institute for Research and Advanced Studies (ICREA). The head of IBEC’s Bacterial Infections: Antimicrobial Therapies group received the award in the Life and Health Sciences category.

December 5, 2024November 27, 2024

IBEC hosts the EU Project SPM4.0 kick-off meeting

Researchers from across Europe gathered for the kick-off meeting of the SPM4.0 project, an innovative Marie Curie Skłodowska Doctoral Network (MSCA-DN) dedicated to advancing the capabilities of autonomous Scanning Probe … Read more

October 29, 2024

Histones against bacterial infections

Research led by IBEC has analysed the antimicrobial activity of human histones against various bacteria, both in solution and in biofilm. The results are very promising and open the door to finding new, more effective treatments, particularly against Pseudomonas aeruginosa infections. This bacterium is mainly responsible for the development of chronic wounds and lung failure in patients with cystic fibrosis and other respiratory diseases.

December 5, 2024July 30, 2024

Two projects with IBEC participation selected in the MSCA call for PhD networks

IBEC will coordinate SPM4.0 and participate as a partner in ENTRY-DM, two of the projects selected in the 2023 call for PhD networks within the Marie Skłodowska-Curie Actions (MSCA). Thanks to these two projects, IBEC will add three new PhD students to its staff.

June 16, 2023

New Faster Future campaign tackles bacterial resistance

IBEC dedicates the 4th edition of its fundraising program, Faster Future, to develop novel strategies to treat infections and diseases caused by antibiotic-resistant bacteria. Specifically, the research seeks to fight … Read more

March 6, 2023March 2, 2023

New strategy against chronic wound infections

Chronic wounds are a challenge for microbiologists due to biofilms, complex structures where bacteria protect themselves from antibiotics, preventing infections from being treated effectively. A research team led by the … Read more

January 30, 2023January 25, 2023

IBEC researchers discover how to improve the existing antibiotics and develop new antimicrobial treatments

In a new study carried out by researchers from the Institute for Bioengineering of Catalonia (IBEC), improved so that they are more effective in much smaller doses, which opens the … Read more

June 23, 2016

Mycobacterium in olive oil for cancer treatment

Researchers at the Autonomous University of Barcelona (UAB) and Institute for Bioengineering of Catalonia (IBEC) have revealed a way to effectively deliver a mycobacterium needed for the treatment of bladder cancer in humans –using a formulation based on olive oil.

The researchers have found a way to reduce the natural clumping that occurs when mycobacteria cells, which possess a high content of lipids in their walls, are introduced to the usual aqueous solutions that are used for intravesical instillation in bladder cancer patients. This clumping may interfere with the interaction of the mycobacteria-host cells and negatively influence their antitumor effects.